ArriVent BioPharma Changes Auditors
Ticker: AVBP · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1868279
| Field | Detail |
|---|---|
| Company | Arrivent Biopharma, INC. (AVBP) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
ArriVent BioPharma swapped auditors from EY to PwC, effective March 11, 2025.
AI Summary
ArriVent BioPharma, Inc. announced on March 11, 2025, a change in its certifying accountant. The company has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm, replacing Ernst & Young LLP. This change is effective immediately.
Why It Matters
A change in auditors can signal potential shifts in financial reporting scrutiny or strategic direction for the company.
Risk Assessment
Risk Level: low — This filing reports a routine change in the company's independent auditor, which typically does not carry significant immediate risk.
Key Players & Entities
- ArriVent BioPharma, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — New Certifying Accountant
- Ernst & Young LLP (company) — Former Certifying Accountant
- March 11, 2025 (date) — Effective Date of Change
FAQ
Who is ArriVent BioPharma, Inc.'s new independent registered public accounting firm?
ArriVent BioPharma, Inc. has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm.
Who was ArriVent BioPharma, Inc.'s previous independent registered public accounting firm?
ArriVent BioPharma, Inc.'s previous independent registered public accounting firm was Ernst & Young LLP.
When was the change in ArriVent BioPharma, Inc.'s certifying accountant effective?
The change in ArriVent BioPharma, Inc.'s certifying accountant was effective as of March 11, 2025.
What is the exact name of the registrant?
The exact name of the registrant is ArriVent BioPharma, Inc.
In which state was ArriVent BioPharma, Inc. incorporated?
ArriVent BioPharma, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding ArriVent BioPharma, Inc. (AVBP).